Eribulin in Advanced Solitary Fibrous Tumor

NCT03840772 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

16

Enrollment

NETWORK

Sponsor class

Conditions

Solitary Fibrous Tumor

Interventions

DRUG: Eribulin

Sponsor

Italian Sarcoma Group

Collaborators

[object Object]